The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Chemoresistance in gastric-type mucinous adenocarcinoma of the uterine cervix: Multi-institutional study by Sankai Gynecology Study Group (SGSG).
Atsumi Kojima
No relevant relationships to disclose
Muneaki Shimada
No relevant relationships to disclose
Shoji Nagao
No relevant relationships to disclose
Nobuhiro Takeshima
No relevant relationships to disclose
Tadahiro Shoji
No relevant relationships to disclose
Tamotsu Sudo
No relevant relationships to disclose
Eiji Hirata
No relevant relationships to disclose
Kazuhiro Takehara
No relevant relationships to disclose
Yasunobu Kanamori
No relevant relationships to disclose
Ryouji Hayase
No relevant relationships to disclose
Norihiro Teramoto
No relevant relationships to disclose
Takako Kiyokawa
No relevant relationships to disclose
Yoshiki Mikami
No relevant relationships to disclose
Junzo Kigawa
No relevant relationships to disclose
Ryuichiro Nishimura
No relevant relationships to disclose